Glenn Garmont | IR, LifeSci Advisors |
Ronald Andrews | CEO, President |
Al Parker | Chief Operating Officer |
Mitchell Levine | CFO |
Tony Kalajian | Chief Accounting Officer |
Lyndal Hesterberg | Chief Scientific Officer |
Paul Knight | Janney Montgomery Scott |
Thomas Flaten | Lake Street Capital Markets |
Bruce Jackson | The Benchmark Company |
Keay Nakae | Chardan Capital Markets |
Greetings, and welcome to the OncoCyte Corporation Second Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow for the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Glenn Garmont with LifeSci Advisors.